VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2017 | Explaining biosimilars to our patients

Paul Cornes, MD, University Hospital Bristol NHS Foundation Trust, Bristol, UK, talks to us about some of the challenges we’ll face now that two biosimilar rituximab agents have been approved for use in the UK. Physicians are now understanding the approval pathway for these drugs and are gaining more trust in the regulators. But we have a lot to learn if we are to convince patients and take them with us on this journey.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter